| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP30 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 6.47e-09 | 279 | 113 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP30 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.94e-06 | 507 | 113 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP30 TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 5.94e-06 | 507 | 113 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D ARHGAP30 TBC1D3C TBC1D3B SH3PXD2B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.03e-05 | 656 | 113 | 14 | GO:0008047 |
| GeneOntologyMolecularFunction | histone methyltransferase binding | 1.35e-04 | 18 | 113 | 3 | GO:1990226 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 6.69e-04 | 70 | 113 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 8.69e-04 | 8 | 113 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 TBC1D3E TBC1D3 TBC1D3H TBC1D3L CRIM1 TBC1D3D TPRN ARHGAP30 TBC1D3C TBC1D3B THBS1 SH3PXD2B TBC1D3I TBC1D3G TBC1D3K INKA1 TBC1D3F | 9.95e-04 | 1418 | 113 | 18 | GO:0030234 |
| GeneOntologyMolecularFunction | protein domain specific binding | WIPF1 HSP90AB4P CRIM1 NUMA1 CBX3 PIAS1 GJA5 SH3PXD2B WIZ FMN1 LRP2 TP53BP2 KPNB1 | 1.35e-03 | 875 | 113 | 13 | GO:0019904 |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.39e-03 | 10 | 113 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 1.39e-03 | 39 | 113 | 3 | GO:0097718 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.41e-11 | 109 | 115 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.22e-07 | 244 | 115 | 11 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.79e-06 | 335 | 115 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 9.35e-05 | 131 | 115 | 6 | GO:0030510 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.10e-04 | 499 | 115 | 11 | GO:0051345 |
| Domain | TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 2.95e-13 | 49 | 113 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 6.87e-13 | 53 | 113 | 10 | PF00566 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.02e-12 | 55 | 113 | 10 | IPR000195 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.02e-12 | 55 | 113 | 10 | PS50086 |
| Domain | EGF_CA | 1.36e-05 | 86 | 113 | 6 | PF07645 | |
| Domain | VWC | 8.00e-05 | 38 | 113 | 4 | SM00214 | |
| Domain | EGF | 9.17e-05 | 235 | 113 | 8 | SM00181 | |
| Domain | EGF_CA | 9.81e-05 | 122 | 113 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.07e-04 | 124 | 113 | 6 | IPR001881 | |
| Domain | ChSh | 1.08e-04 | 3 | 113 | 2 | SM00300 | |
| Domain | Chromo_shadow_dom | 1.08e-04 | 3 | 113 | 2 | IPR008251 | |
| Domain | Chromo_shadow | 1.08e-04 | 3 | 113 | 2 | PF01393 | |
| Domain | VWF_dom | 1.19e-04 | 42 | 113 | 4 | IPR001007 | |
| Domain | EGF-like_dom | 1.37e-04 | 249 | 113 | 8 | IPR000742 | |
| Domain | FYrich_C | 3.59e-04 | 5 | 113 | 2 | IPR003889 | |
| Domain | FYrich_N | 3.59e-04 | 5 | 113 | 2 | IPR003888 | |
| Domain | FYRC | 3.59e-04 | 5 | 113 | 2 | SM00542 | |
| Domain | FYRN | 3.59e-04 | 5 | 113 | 2 | SM00541 | |
| Domain | TSP_3 | 3.59e-04 | 5 | 113 | 2 | PF02412 | |
| Domain | TSP3 | 3.59e-04 | 5 | 113 | 2 | PS51234 | |
| Domain | TSP_CTER | 3.59e-04 | 5 | 113 | 2 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 3.59e-04 | 5 | 113 | 2 | IPR017897 | |
| Domain | TSP_type-3_rpt | 3.59e-04 | 5 | 113 | 2 | IPR028974 | |
| Domain | - | 3.59e-04 | 5 | 113 | 2 | 4.10.1080.10 | |
| Domain | FYRN | 3.59e-04 | 5 | 113 | 2 | PF05964 | |
| Domain | FYRC | 3.59e-04 | 5 | 113 | 2 | PF05965 | |
| Domain | Thrombospondin_C | 3.59e-04 | 5 | 113 | 2 | IPR008859 | |
| Domain | FYRC | 3.59e-04 | 5 | 113 | 2 | PS51543 | |
| Domain | FYRN | 3.59e-04 | 5 | 113 | 2 | PS51542 | |
| Domain | TSP_C | 3.59e-04 | 5 | 113 | 2 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 3.59e-04 | 5 | 113 | 2 | IPR003367 | |
| Domain | SCAN | 3.66e-04 | 56 | 113 | 4 | SM00431 | |
| Domain | Growth_fac_rcpt_ | 3.73e-04 | 156 | 113 | 6 | IPR009030 | |
| Domain | Chromo_domain | 3.98e-04 | 24 | 113 | 3 | IPR023780 | |
| Domain | SCAN_BOX | 4.19e-04 | 58 | 113 | 4 | PS50804 | |
| Domain | SCAN | 4.19e-04 | 58 | 113 | 4 | PF02023 | |
| Domain | SCAN_dom | 4.19e-04 | 58 | 113 | 4 | IPR003309 | |
| Domain | Retrov_capsid_C | 4.47e-04 | 59 | 113 | 4 | IPR008916 | |
| Domain | Chromo | 5.07e-04 | 26 | 113 | 3 | PF00385 | |
| Domain | CHROMO_1 | 6.33e-04 | 28 | 113 | 3 | PS00598 | |
| Domain | CHROMO_2 | 6.33e-04 | 28 | 113 | 3 | PS50013 | |
| Domain | VWC | 6.33e-04 | 28 | 113 | 3 | PF00093 | |
| Domain | EGF_1 | 9.21e-04 | 255 | 113 | 7 | PS00022 | |
| Domain | Chromodomain-like | 9.41e-04 | 32 | 113 | 3 | IPR016197 | |
| Domain | Chromo/shadow_dom | 1.03e-03 | 33 | 113 | 3 | IPR000953 | |
| Domain | CHROMO | 1.03e-03 | 33 | 113 | 3 | SM00298 | |
| Domain | EGF-like_CS | 1.05e-03 | 261 | 113 | 7 | IPR013032 | |
| Domain | PHD | 1.11e-03 | 75 | 113 | 4 | PF00628 | |
| Domain | EGF_2 | 1.15e-03 | 265 | 113 | 7 | PS01186 | |
| Domain | VWFC_1 | 1.33e-03 | 36 | 113 | 3 | PS01208 | |
| Domain | Znf_PHD-finger | 1.35e-03 | 79 | 113 | 4 | IPR019787 | |
| Domain | VWFC_2 | 1.56e-03 | 38 | 113 | 3 | PS50184 | |
| Domain | Chromo_dom_subgr | 1.58e-03 | 10 | 113 | 2 | IPR017984 | |
| Domain | BROMODOMAIN_2 | 1.94e-03 | 41 | 113 | 3 | PS50014 | |
| Domain | Znf_FYVE_PHD | 2.00e-03 | 147 | 113 | 5 | IPR011011 | |
| Domain | Bromodomain | 2.08e-03 | 42 | 113 | 3 | IPR001487 | |
| Domain | BROMO | 2.08e-03 | 42 | 113 | 3 | SM00297 | |
| Domain | - | 2.08e-03 | 42 | 113 | 3 | 1.20.920.10 | |
| Domain | PHD | 2.09e-03 | 89 | 113 | 4 | SM00249 | |
| Domain | Znf_PHD | 2.27e-03 | 91 | 113 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.65e-03 | 95 | 113 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.75e-03 | 96 | 113 | 4 | PS01359 | |
| Domain | EGF_Ca-bd_CS | 2.86e-03 | 97 | 113 | 4 | IPR018097 | |
| Domain | EGF_3 | 3.07e-03 | 235 | 113 | 6 | PS50026 | |
| Domain | EGF_CA | 3.08e-03 | 99 | 113 | 4 | PS01187 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.15e-03 | 14 | 113 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.15e-03 | 14 | 113 | 2 | IPR024743 | |
| Domain | TIL_dom | 3.15e-03 | 14 | 113 | 2 | IPR002919 | |
| Domain | MT | 3.15e-03 | 14 | 113 | 2 | PF12777 | |
| Domain | AAA_8 | 3.15e-03 | 14 | 113 | 2 | PF12780 | |
| Domain | ASX_HYDROXYL | 3.19e-03 | 100 | 113 | 4 | PS00010 | |
| Domain | DHC_fam | 3.62e-03 | 15 | 113 | 2 | IPR026983 | |
| Domain | Bbox_C | 3.62e-03 | 15 | 113 | 2 | IPR003649 | |
| Domain | BBC | 3.62e-03 | 15 | 113 | 2 | SM00502 | |
| Domain | Dynein_heavy | 3.62e-03 | 15 | 113 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.62e-03 | 15 | 113 | 2 | IPR004273 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.93e-03 | 106 | 113 | 4 | IPR000152 | |
| Domain | Post-SET_dom | 4.12e-03 | 16 | 113 | 2 | IPR003616 | |
| Domain | PostSET | 4.12e-03 | 16 | 113 | 2 | SM00508 | |
| Domain | AT_hook | 4.12e-03 | 16 | 113 | 2 | PF02178 | |
| Domain | POST_SET | 4.12e-03 | 16 | 113 | 2 | PS50868 | |
| Domain | Chromodomain_CS | 5.21e-03 | 18 | 113 | 2 | IPR023779 | |
| Domain | EGF_extracell | 5.74e-03 | 60 | 113 | 3 | IPR013111 | |
| Domain | EGF_2 | 5.74e-03 | 60 | 113 | 3 | PF07974 | |
| Domain | VWC_out | 5.80e-03 | 19 | 113 | 2 | SM00215 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K | 6.14e-09 | 99 | 83 | 9 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 3.49e-28 | 11 | 116 | 11 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | TBC1D3E TBC1D3 TBC1D3H TBC1D3D TBC1D3B CORO6 TBC1D3G GSG1L2 TBC1D3F | 3.43e-12 | 74 | 116 | 9 | 16625196 |
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 1.44e-07 | 4 | 116 | 3 | 12359748 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 8406013 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 12604796 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 8471161 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 10562550 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 7.36e-06 | 394 | 116 | 9 | 27248496 | |
| Pubmed | 1.01e-05 | 13 | 116 | 3 | 15322135 | ||
| Pubmed | 1.01e-05 | 13 | 116 | 3 | 8978696 | ||
| Pubmed | 1.06e-05 | 86 | 116 | 5 | 37253089 | ||
| Pubmed | Trim24 and Trim33 Play a Role in Epigenetic Silencing of Retroviruses in Embryonic Stem Cells. | 1.10e-05 | 2 | 116 | 2 | 32932986 | |
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 1.10e-05 | 2 | 116 | 2 | 16181801 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 17620335 | ||
| Pubmed | KIF13B-mediated VEGFR2 trafficking is essential for vascular leakage and metastasis in vivo. | 1.10e-05 | 2 | 116 | 2 | 34670814 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 22123502 | ||
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 1.10e-05 | 2 | 116 | 2 | 23660684 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 39122122 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 34425286 | ||
| Pubmed | Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. | 1.10e-05 | 2 | 116 | 2 | 22930728 | |
| Pubmed | Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. | 1.10e-05 | 2 | 116 | 2 | 8126073 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 38339060 | ||
| Pubmed | A sequence motif found in a Drosophila heterochromatin protein is conserved in animals and plants. | 1.10e-05 | 2 | 116 | 2 | 1708124 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 33372257 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 21762961 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 9694593 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 12213711 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 30920297 | ||
| Pubmed | KIF13B mediates VEGFR2 recycling to modulate vascular permeability. | 1.10e-05 | 2 | 116 | 2 | 36928770 | |
| Pubmed | Thrombospondin expression in aldosterone-producing adenomas. | 1.10e-05 | 2 | 116 | 2 | 12358136 | |
| Pubmed | A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. | 1.10e-05 | 2 | 116 | 2 | 1712771 | |
| Pubmed | Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. | 1.10e-05 | 2 | 116 | 2 | 10027393 | |
| Pubmed | KIF13B regulates angiogenesis through Golgi to plasma membrane trafficking of VEGFR2. | 1.10e-05 | 2 | 116 | 2 | 25128562 | |
| Pubmed | Regulation of an inducible promoter by an HP1beta-HP1gamma switch. | 1.10e-05 | 2 | 116 | 2 | 18239689 | |
| Pubmed | Functional domain analysis of human HP1 isoforms in Drosophila. | 1.10e-05 | 2 | 116 | 2 | 17575412 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 33981184 | ||
| Pubmed | Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. | 1.10e-05 | 2 | 116 | 2 | 18594557 | |
| Pubmed | Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. | 1.10e-05 | 2 | 116 | 2 | 15037577 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 30928339 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 17143334 | ||
| Pubmed | Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors. | 1.10e-05 | 2 | 116 | 2 | 33759165 | |
| Pubmed | Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program. | 1.28e-05 | 14 | 116 | 3 | 28729362 | |
| Pubmed | Role of TIF1alpha as a modulator of embryonic transcription in the mouse zygote. | 1.96e-05 | 16 | 116 | 3 | 16880268 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.45e-05 | 351 | 116 | 8 | 38297188 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 26241338 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 9373030 | ||
| Pubmed | Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. | 3.30e-05 | 3 | 116 | 2 | 20923780 | |
| Pubmed | Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. | 3.30e-05 | 3 | 116 | 2 | 18787106 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 10439047 | ||
| Pubmed | Localization and phosphorylation of HP1 proteins during the cell cycle in mammalian cells. | 3.30e-05 | 3 | 116 | 2 | 10460410 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18032585 | ||
| Pubmed | Cloning of the mouse laminin alpha 4 cDNA. Expression in a subset of endothelium. | 3.30e-05 | 3 | 116 | 2 | 9219532 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 12096914 | ||
| Pubmed | Stage-specific expression of polycomb group genes in human bone marrow cells. | 3.30e-05 | 3 | 116 | 2 | 9454751 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19818485 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 36098557 | ||
| Pubmed | HP1gamma function is required for male germ cell survival and spermatogenesis. | 3.30e-05 | 3 | 116 | 2 | 20423503 | |
| Pubmed | EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins. | 3.30e-05 | 3 | 116 | 2 | 17638877 | |
| Pubmed | Differential contribution of HP1 proteins to DNA end resection and homology-directed repair. | 3.30e-05 | 3 | 116 | 2 | 23287531 | |
| Pubmed | Pericentromeric heterochromatin domains are maintained without accumulation of HP1. | 3.30e-05 | 3 | 116 | 2 | 17314413 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23979202 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 30939949 | ||
| Pubmed | Dynamic associations of heterochromatin protein 1 with the nuclear envelope. | 3.30e-05 | 3 | 116 | 2 | 11101528 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 35637952 | ||
| Pubmed | Interactions between CD47 and thrombospondin reduce inflammation. | 3.30e-05 | 3 | 116 | 2 | 17442977 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 36430693 | ||
| Pubmed | Diversity of human copy number variation and multicopy genes. | 3.30e-05 | 3 | 116 | 2 | 21030649 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19004835 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23932714 | ||
| Pubmed | Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. | 3.30e-05 | 3 | 116 | 2 | 8463250 | |
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 3.30e-05 | 3 | 116 | 2 | 12482844 | |
| Pubmed | HP1 proteins compact DNA into mechanically and positionally stable phase separated domains. | 3.30e-05 | 3 | 116 | 2 | 33661100 | |
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 3.30e-05 | 3 | 116 | 2 | 26168731 | |
| Pubmed | Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1. | 3.30e-05 | 3 | 116 | 2 | 16598380 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 32770107 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 27513329 | ||
| Pubmed | N-terminal phosphorylation of HP1{alpha} promotes its chromatin binding. | 3.30e-05 | 3 | 116 | 2 | 21245376 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 15347840 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 25976449 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 31092423 | ||
| Pubmed | Maintenance of stable heterochromatin domains by dynamic HP1 binding. | 3.30e-05 | 3 | 116 | 2 | 12560555 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 3.30e-05 | 3 | 116 | 2 | 1459996 | |
| Pubmed | Gene regulation by human orthologs of Drosophila heterochromatin protein 1. | 3.30e-05 | 3 | 116 | 2 | 12054505 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 18178577 | ||
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 3.30e-05 | 3 | 116 | 2 | 8400410 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 23629965 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17855382 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 33069367 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 5.32e-05 | 22 | 116 | 3 | 26886794 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 19147503 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 17381543 | ||
| Pubmed | Pim-1 associates with protein complexes necessary for mitosis. | 6.59e-05 | 4 | 116 | 2 | 12111331 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 34392614 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 15342492 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 10330177 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 9636146 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 6.59e-05 | 4 | 116 | 2 | 23129768 | |
| Pubmed | E3 ubiquitin ligase HECW2 mediates the proteasomal degradation of HP1 isoforms. | 6.59e-05 | 4 | 116 | 2 | 30208514 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 15166498 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3I TBC1D3G TBC1D3K TBC1D3F | 1.70e-13 | 149 | 116 | 11 | chr17q12 |
| Cytoband | 17q12 | 5.59e-06 | 99 | 116 | 5 | 17q12 | |
| Cytoband | 15q15 | 4.11e-04 | 12 | 116 | 2 | 15q15 | |
| Cytoband | 19q13.12 | 8.26e-04 | 72 | 116 | 3 | 19q13.12 | |
| Cytoband | 7q36.1 | 8.94e-04 | 74 | 116 | 3 | 7q36.1 | |
| GeneFamily | PHD finger proteins | 3.67e-04 | 90 | 68 | 4 | 88 | |
| GeneFamily | Chromobox family | 3.85e-04 | 8 | 68 | 2 | 976 | |
| GeneFamily | Dyneins, cytoplasmic | 1.06e-03 | 13 | 68 | 2 | 538 | |
| GeneFamily | Ankyrin repeat domain containing | 2.16e-03 | 242 | 68 | 5 | 403 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 1.26e-05 | 11 | 113 | 3 | M566 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.97e-05 | 191 | 113 | 7 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.32e-05 | 196 | 113 | 7 | M3008 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B TBC1D3G RAD54L TBC1D3K TBC1D3F | 3.71e-11 | 90 | 110 | 10 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H LDLRAD2 TBC1D3L TBC1D3D LAMB1 TBC1D3C TBC1D3B FBLN2 TBC1D3G ANKRD33B TBC1D3K TBC1D3F | 1.16e-08 | 320 | 110 | 13 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L CRIM1 TBC1D3D TBC1D3C TBC1D3B TONSL KDR TBC1D3G TBC1D3K TBC1D3F | 2.54e-08 | 281 | 110 | 12 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L CRIM1 TBC1D3D TBC1D3C TBC1D3B TONSL KDR TBC1D3G TBC1D3K TBC1D3F | 2.54e-08 | 281 | 110 | 12 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SSC4D KDR TBC1D3G TBC1D3K TBC1D3F | 5.31e-08 | 242 | 110 | 11 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SSC4D TBC1D3G TBC1D3K TBC1D3F | 1.64e-07 | 213 | 110 | 10 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D TBC1D3C TBC1D3B SSC4D TBC1D3G TBC1D3K TBC1D3F | 1.64e-07 | 213 | 110 | 10 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | RGPD4 KIF13B TBC1D3 TBC1D3H LDLRAD2 TBC1D3L TBC1D3D LAMB1 TBC1D3C TBC1D3B KLHL22 TYRO3 SSC4D FBLN2 TBC1D3G ANKRD33B TBC1D3K TBC1D3F | 2.55e-05 | 1153 | 110 | 18 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3H TBC1D3L TBC1D3D NUMA1 LAMB1 PAGR1 PIAS1 TBC1D3C TBC1D3B LRP2 PPIP5K1 LTBP2 TBC1D3G ANKRD33B TBC1D3K TBC1D3F | 3.74e-05 | 1075 | 110 | 17 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.81e-06 | 184 | 116 | 6 | b8ecf58b3bdb25bcba5efc2d764930bb84ab95c8 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.81e-06 | 184 | 116 | 6 | b232a9cc1d14e1a134b037016d437b93921a4a0f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.37e-06 | 186 | 116 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-06 | 186 | 116 | 6 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 192 | 116 | 6 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.16e-05 | 193 | 116 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.19e-05 | 194 | 116 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.19e-05 | 194 | 116 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.23e-05 | 195 | 116 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-05 | 198 | 116 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.38e-05 | 199 | 116 | 6 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.38e-05 | 199 | 116 | 6 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-05 | 200 | 116 | 6 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-05 | 200 | 116 | 6 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-05 | 200 | 116 | 6 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 200 | 116 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-05 | 200 | 116 | 6 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-05 | 200 | 116 | 6 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 147 | 116 | 5 | 2885978bcfc5623967c0c1204dadf5c78c74a082 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 5.53e-05 | 156 | 116 | 5 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.53e-05 | 156 | 116 | 5 | 8349604bd801e20d33770f7d8243598c3756302b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 7.85e-05 | 168 | 116 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Lymphoid_DC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.85e-05 | 168 | 116 | 5 | 6dd58fd981750da49afd53796f244e1803cce97f | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.85e-05 | 168 | 116 | 5 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.85e-05 | 168 | 116 | 5 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.85e-05 | 168 | 116 | 5 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 8.07e-05 | 169 | 116 | 5 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 8.53e-05 | 171 | 116 | 5 | fcc31a9a69f96de10d1324a5a4fbfe4289bf4984 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 171 | 116 | 5 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 171 | 116 | 5 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Neutrophil|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-05 | 176 | 116 | 5 | 676839d07450b313222622e0ffd305c732cbad6d | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.03e-04 | 178 | 116 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.03e-04 | 178 | 116 | 5 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 181 | 116 | 5 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | CD8+_Memory_T_cell-RSV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.14e-04 | 182 | 116 | 5 | f5f17a80552f0ad05ed1a2529a04ee55deb1e130 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 183 | 116 | 5 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 185 | 116 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 186 | 116 | 5 | e3a14f3ccadbf3211822c67b8956ee01f563307a | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 187 | 116 | 5 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 187 | 116 | 5 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 187 | 116 | 5 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.33e-04 | 188 | 116 | 5 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-04 | 188 | 116 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-04 | 188 | 116 | 5 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-04 | 189 | 116 | 5 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 190 | 116 | 5 | 9d5242759546be0089981ef1877e4ed5f81face5 | |
| ToppCell | IPF-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.40e-04 | 190 | 116 | 5 | ffa890138394f579fee53fcfac6c121bf86adc26 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.40e-04 | 190 | 116 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 190 | 116 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.43e-04 | 191 | 116 | 5 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 192 | 116 | 5 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 192 | 116 | 5 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.47e-04 | 192 | 116 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 192 | 116 | 5 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.47e-04 | 192 | 116 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 192 | 116 | 5 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 193 | 116 | 5 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.50e-04 | 193 | 116 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.54e-04 | 194 | 116 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.54e-04 | 194 | 116 | 5 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.58e-04 | 195 | 116 | 5 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 195 | 116 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 195 | 116 | 5 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.58e-04 | 195 | 116 | 5 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.62e-04 | 196 | 116 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.62e-04 | 196 | 116 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.66e-04 | 197 | 116 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 197 | 116 | 5 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 197 | 116 | 5 | b11a5d909942a4299cbc0b27332b1a3f66f3bccd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.66e-04 | 197 | 116 | 5 | 4d3670456655248250d156f92de01df4aa481733 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.66e-04 | 197 | 116 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.66e-04 | 197 | 116 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.66e-04 | 197 | 116 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.69e-04 | 198 | 116 | 5 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | (5)_Dendritic_cell-(53)_Lymphoid_DC|(5)_Dendritic_cell / shred on Cell_type and subtype | 1.69e-04 | 198 | 116 | 5 | 548da5fa86f9756c503ed77bcdde55bc4d1a2726 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 198 | 116 | 5 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.69e-04 | 198 | 116 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-MAIT|URO / Disease, condition lineage and cell class | 1.69e-04 | 198 | 116 | 5 | 75db638278d4be2b0f406cd8871058a8352c5a86 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 1.69e-04 | 198 | 116 | 5 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.69e-04 | 198 | 116 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-04 | 198 | 116 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-04 | 198 | 116 | 5 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.73e-04 | 199 | 116 | 5 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 199 | 116 | 5 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-04 | 199 | 116 | 5 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 199 | 116 | 5 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.78e-04 | 200 | 116 | 5 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.78e-04 | 200 | 116 | 5 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 200 | 116 | 5 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | COVID-19-Fibroblasts-Pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.78e-04 | 200 | 116 | 5 | 73e01b7bc43320a991c67a4fd0c04708f893c7ea | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.78e-04 | 200 | 116 | 5 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-04 | 200 | 116 | 5 | ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 200 | 116 | 5 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 200 | 116 | 5 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 200 | 116 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 200 | 116 | 5 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-04 | 200 | 116 | 5 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 200 | 116 | 5 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.14e-04 | 69 | 106 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | myelofibrosis (is_implicated_in) | 3.53e-04 | 8 | 106 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | hearing impairment | 4.38e-04 | 98 | 106 | 4 | C1384666 | |
| Disease | cancer biomarker measurement | 1.30e-03 | 15 | 106 | 2 | EFO_0005127 | |
| Disease | Diabetic Angiopathies | 1.48e-03 | 16 | 106 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 1.48e-03 | 16 | 106 | 2 | C0025945 | |
| Disease | diffuse plaque measurement | 1.66e-03 | 758 | 106 | 9 | EFO_0010699 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 1.68e-03 | 17 | 106 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | hemorrhoid | 1.98e-03 | 147 | 106 | 4 | EFO_0009552 | |
| Disease | CCL4 measurement | 2.33e-03 | 20 | 106 | 2 | EFO_0004751 | |
| Disease | Liver carcinoma | 2.40e-03 | 507 | 106 | 7 | C2239176 | |
| Disease | prostate cancer (is_marker_for) | 2.46e-03 | 156 | 106 | 4 | DOID:10283 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NSLQDRSCGEELPWD | 361 | Q495M9 | |
| KDSLNCEWVIEAEPG | 916 | Q7Z407 | |
| DADNTWEPEENLDCP | 56 | Q13185 | |
| EDCVEVQPDGRWNDD | 276 | P07307 | |
| DWLASCNPDALFQED | 1711 | Q9P2D1 | |
| DDDQWLDLSPDQLDQ | 411 | O95905 | |
| PEENCGILEWEDREQ | 186 | Q9UKW6 | |
| AEVWCGSERPVADNE | 46 | Q13625 | |
| AECPHVDVNWQDSEG | 141 | A6NCL7 | |
| CSDEEVELPADGQPW | 91 | Q9BTK6 | |
| EGRSCDDEDWQPGLV | 16 | Q92698 | |
| DFWEPDVNAENCDSS | 206 | P21918 | |
| DGDPVAESVWELDCE | 446 | P21918 | |
| LAPEDDCFQSAGDWQ | 126 | Q68DA7 | |
| GLWQSCEESLNGEDE | 91 | A8MUP6 | |
| LDGCLEVPWEQEGAA | 601 | Q86XR2 | |
| TPDACLEHWQGLEAE | 156 | Q96EL1 | |
| CFSPELNEWTEDDEL | 586 | Q9H511 | |
| DTDCGLWVQAAAPGD | 61 | Q5SZI1 | |
| ISEQLPCRDDGWSEQ | 1311 | Q8NEZ4 | |
| AAADGLPCWNGEDIV | 411 | P78333 | |
| IWTRNPDDITQEECG | 261 | Q58FF6 | |
| DDEDGQNLWSCILSE | 41 | Q9Y6G9 | |
| QWAIDNDECLEIPES | 451 | P98095 | |
| QPGCVEESFESWLED | 261 | A0A0J9YX94 | |
| DWIVDNEGLTSLPCQ | 606 | Q96KP1 | |
| EKEENEGLATIPACW | 351 | Q9ULS6 | |
| LSCSPQDEDEERWQG | 411 | Q8NG66 | |
| DQCLPEHWGLSNDLD | 491 | P07942 | |
| QEGDWSQQELHCEDP | 436 | Q8N9T8 | |
| IPNSWVCDQDQDCDD | 81 | P98164 | |
| APGTLEWQLQACEDQ | 116 | P27918 | |
| WEQPGQAALSEELCQ | 596 | O94927 | |
| LCDEASWFESNDNPE | 781 | Q9Y5G1 | |
| EDQAALAAGPWEECF | 6 | O14732 | |
| LPDVSCWDIDQEGDS | 301 | P09884 | |
| DESEILEESPCGRWQ | 51 | Q9UHY1 | |
| QDVSSWIICDGDIDP | 2046 | Q8NCM8 | |
| GAWLCDDNFPDDESR | 2191 | Q9ULT8 | |
| QLFCEATEWIQDPDE | 246 | Q93033 | |
| VIFCWGDDTNDPENR | 581 | Q9NPB8 | |
| DCWEEGPQLDNSISG | 571 | Q53GT1 | |
| DTLHLPVWVDNDGNC | 506 | Q9Y223 | |
| PVWVDNDGNCAALAE | 511 | Q9Y223 | |
| EANDREGDPCDLWVT | 471 | A8K855 | |
| LQLAPGQEVWADELC | 806 | Q9Y6R7 | |
| PVAEKAELSCWEEGN | 126 | P36382 | |
| AADCEVEQWDSDEPI | 26 | Q9UBQ7 | |
| SDEDNTWEPEENLDC | 46 | P83916 | |
| TWEPEENLDCPDLIA | 51 | P83916 | |
| AGVCEDENWTDDQLL | 106 | Q9NZV1 | |
| WDPQAEATLSCHEGD | 166 | Q8IYS4 | |
| EEDETASENCFPWNV | 511 | Q49MI3 | |
| PALEADEWLSGQDAE | 371 | Q6QEF8 | |
| EQCEFIPWSDLVPND | 1841 | Q0VDD8 | |
| DQGFEISPSGWDCVD | 1331 | Q14767 | |
| NDDDDDWNPCKAAGV | 336 | Q14974 | |
| WKLGDCGPQDDDTES | 181 | P42701 | |
| EENERPLEDQLENWC | 1461 | Q03164 | |
| WAQEGSEPVLLEGEC | 31 | Q6UW01 | |
| LPAECLDIDGDWNTL | 391 | Q49AJ0 | |
| TCQDEPEQLDDWNRI | 1906 | Q14980 | |
| EQACWEVGEDKQAEP | 651 | Q7Z6I6 | |
| GCPEEAAAVWESLQQ | 86 | Q496H8 | |
| DNLDDPEAGGWDATL | 1186 | Q9NQT8 | |
| QSLTQIDLEGNPWDC | 521 | Q8IW52 | |
| ENTGPTLEWDNCDLR | 1241 | Q7Z3J3 | |
| GDGNNKDDDPNEDWC | 876 | Q9UPN9 | |
| EVCLPGAWQADDNAV | 636 | Q96PX1 | |
| EEEWNALQSVENCPE | 66 | Q86UA6 | |
| NDIDARPWDFQAEEC | 751 | Q9ULQ0 | |
| CAEEEGDIEWQLNAS | 426 | Q96NG3 | |
| GCRSVELDVWDGPDN | 466 | Q9UPR0 | |
| CEVEFQGPLSIQEEW | 1601 | O95785 | |
| EEDPTWEQVCNSQEG | 21 | Q96JS3 | |
| DCDEIQFKEDGTWAP | 401 | O75925 | |
| EDQLAPCWQAEHPAE | 486 | B9A6J9 | |
| QDDKNWDEDEPICIP | 2816 | Q4LDE5 | |
| WLESQIQEGCEEPAT | 861 | P53675 | |
| VSWIQGEGEDPCVEA | 31 | Q9P2E5 | |
| CSRLFDNDLPDGWEE | 151 | Q9HAU4 | |
| EDQLAPCWQAEHPAE | 486 | A6NDS4 | |
| EDQLAPCWQAEHPAE | 486 | P0C7X1 | |
| GETRKEDDPNEDWCA | 816 | O15164 | |
| EDDPNEDWCAVCQNG | 821 | O15164 | |
| CLLLSGRDNWEDEPQ | 316 | Q6RFH5 | |
| EDTDLDGWPNENLVC | 691 | P07996 | |
| SQEEWDCLDPVQRDL | 16 | Q8NA42 | |
| AVCQPLDWGEDSENE | 656 | P17040 | |
| DLWPGCDVGEDQLDS | 1156 | Q8IWN7 | |
| CDVGEDQLDSGLWEL | 1161 | Q8IWN7 | |
| EDQLAPCWQAEHPAE | 486 | A6NER0 | |
| GTVCDDDWGLPDAAV | 211 | Q8WTU2 | |
| EEQGWVPATCLEGQD | 196 | A1X283 | |
| QAALIPEEECLAGDW | 821 | Q96HA7 | |
| GEQEETALCRGAWEP | 136 | Q6NSZ9 | |
| WSAEEELLCVQEDGA | 91 | Q9H269 | |
| EGWENVDDSSCQLVP | 316 | Q8IV45 | |
| SIRNGFQDSPCEDEW | 436 | O43516 | |
| EDQLAPCWQAEHPAE | 486 | A0A087X179 | |
| VWESILEECGLQEGD | 121 | Q147U7 | |
| WENCEEEEKTNPGLQ | 331 | P40238 | |
| IDAAEWEDIINECDP | 261 | Q96JH7 | |
| PEACGDHEQWTLVAD | 21 | Q9NWT1 | |
| LEVEAQWAVEEGACP | 386 | Q4KMQ1 | |
| EPQLLWDCDNESENS | 176 | P49910 | |
| DGVCFTEQEWENLED | 146 | Q9UDV6 | |
| CPENGWDESTLELFL | 41 | Q9HD40 | |
| EDQLAPCWQAEHPAE | 486 | A0A087WVF3 | |
| PCEEWRSVEDFQGGN | 481 | P35968 | |
| CGEDSDLDGWPNLNL | 691 | P35442 | |
| EDQLAPCWQAEHPAE | 486 | Q6DHY5 | |
| EDQLAPCWQAEHPAE | 486 | Q8IZP1 | |
| LEEDDGTGLCHWPLQ | 176 | Q68DK2 | |
| SQEEWECLDPAQRDL | 16 | Q7Z3V5 | |
| EDQLAPCWQAEHPAE | 486 | A0A087X1G2 | |
| WCQVEDGGETEISQP | 116 | Q06418 | |
| EDVILNEPVENWPSC | 91 | Q6PFW1 | |
| EDQLAPCWQAEHPAE | 486 | A0A087WXS9 | |
| EDQLAPCWQAEHPAE | 486 | Q6IPX1 | |
| DFSQEEWECLDPAQR | 81 | Q8N7M2 |